Linking Body Composition and Nutritional Status with CAR T-cell Efficacy.
Mariam T NawasMichael ScordoPublished in: Cancer immunology research (2023)
Obesity and its attendant pathophysiological alterations have long been implicated in promoting cancer development and in the modulation of antitumor immunologic responses, but little is known about their impact on outcomes after cellular immunotherapy. In this issue, Rejeski and colleagues report that intrinsic host factors including body composition and nutritional status may predict response after chimeric antigen receptor T-cell therapy in patients with relapsed lymphomas. These data highlight the clinical relevance of these factors on treatment outcomes and will hopefully motivate interventional studies of prehabilitation and nutritional optimization in these patients. See related article by Rejeski et al., p. 707 (1).
Keyphrases
- body composition
- cell therapy
- resistance training
- bone mineral density
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- weight loss
- peritoneal dialysis
- mesenchymal stem cells
- acute myeloid leukemia
- insulin resistance
- papillary thyroid
- electronic health record
- diffuse large b cell lymphoma
- young adults
- multiple myeloma
- big data
- squamous cell carcinoma
- artificial intelligence
- hodgkin lymphoma
- deep learning
- skeletal muscle
- patient reported outcomes
- postmenopausal women
- physical activity